Women's experiences of receiving care for pelvic organ prolapse: a qualitative study.


Journal

BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690

Informations de publication

Date de publication:
15 03 2019
Historique:
received: 01 11 2018
accepted: 08 03 2019
entrez: 17 3 2019
pubmed: 17 3 2019
medline: 16 7 2019
Statut: epublish

Résumé

Pelvic organ prolapse is a common urogenital condition affecting 41-50% of women over the age of 40. To achieve early diagnosis and appropriate treatment, it is important that care is sensitive to and meets women's needs, throughout their patient journey. This study explored women's experiences of seeking diagnosis and treatment for prolapse and their needs and priorities for improving person-centred care. Twenty-two women receiving prolapse care through urogynaecology services across three purposefully selected NHS UK sites took part in three focus groups and four telephone interviews. A topic guide facilitated discussions about women's experiences of prolapse, diagnosis, treatment, follow-up, interactions with healthcare professionals, overall service delivery, and ideals for future services to meet their needs. Data were analysed thematically. Three themes emerged relating to women's experiences of a) Evaluating what is normal b) Hobson's choice of treatment decisions, and c) The trial and error of treatment and technique. Women often delayed seeking help for their symptoms due to lack of awareness, embarrassment and stigma. When presented to GPs, their symptoms were often dismissed and unaddressed until they became more severe. Women reported receiving little or no choice in treatment decisions. Choices were often influenced by health professionals' preferences which were subtly reflected through the framing of the offer. Women's embodied knowledge of their condition and treatment was largely unheeded, resulting in decisions that were inconsistent with women's preferences and needs. Physiotherapy based interventions were reported as helping women regain control over their symptoms and life. A need for greater awareness of prolapse and physiotherapy interventions among women, GPs and consultants was identified alongside greater focus on prevention, early diagnosis and regular follow-up. Greater choice and involvement in treatment decision making was desired. As prolapse treatment options expand to include more conservative choices, greater awareness and education is needed among women and professionals about these as a first line treatment and preventive measure, alongside a multi-professional team approach to treatment decision making. Women presenting with prolapse symptoms need to be listened to by the health care team, offered better information about treatment choices, and supported to make a decision that is right for them.

Sections du résumé

BACKGROUND
Pelvic organ prolapse is a common urogenital condition affecting 41-50% of women over the age of 40. To achieve early diagnosis and appropriate treatment, it is important that care is sensitive to and meets women's needs, throughout their patient journey. This study explored women's experiences of seeking diagnosis and treatment for prolapse and their needs and priorities for improving person-centred care.
METHODS
Twenty-two women receiving prolapse care through urogynaecology services across three purposefully selected NHS UK sites took part in three focus groups and four telephone interviews. A topic guide facilitated discussions about women's experiences of prolapse, diagnosis, treatment, follow-up, interactions with healthcare professionals, overall service delivery, and ideals for future services to meet their needs. Data were analysed thematically.
RESULTS
Three themes emerged relating to women's experiences of a) Evaluating what is normal b) Hobson's choice of treatment decisions, and c) The trial and error of treatment and technique. Women often delayed seeking help for their symptoms due to lack of awareness, embarrassment and stigma. When presented to GPs, their symptoms were often dismissed and unaddressed until they became more severe. Women reported receiving little or no choice in treatment decisions. Choices were often influenced by health professionals' preferences which were subtly reflected through the framing of the offer. Women's embodied knowledge of their condition and treatment was largely unheeded, resulting in decisions that were inconsistent with women's preferences and needs. Physiotherapy based interventions were reported as helping women regain control over their symptoms and life. A need for greater awareness of prolapse and physiotherapy interventions among women, GPs and consultants was identified alongside greater focus on prevention, early diagnosis and regular follow-up. Greater choice and involvement in treatment decision making was desired.
CONCLUSIONS
As prolapse treatment options expand to include more conservative choices, greater awareness and education is needed among women and professionals about these as a first line treatment and preventive measure, alongside a multi-professional team approach to treatment decision making. Women presenting with prolapse symptoms need to be listened to by the health care team, offered better information about treatment choices, and supported to make a decision that is right for them.

Identifiants

pubmed: 30876415
doi: 10.1186/s12905-019-0741-2
pii: 10.1186/s12905-019-0741-2
pmc: PMC6419797
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

45

Subventions

Organisme : Department of Health
ID : 14/04/02
Pays : United Kingdom
Organisme : Department of Health
ID : 14-04-02
Pays : United Kingdom

Références

MedGenMed. 2001 Mar 05;3(2):2
pubmed: 11549951
BJOG. 2008 Oct;115(11):1362-8
pubmed: 18715245
Cochrane Database Syst Rev. 2011 Dec 07;(12):CD003882
pubmed: 22161382
JAMA. 1992 Apr 22-29;267(16):2221-6
pubmed: 1556799
Cochrane Database Syst Rev. 2013 Feb 28;(2):CD004010
pubmed: 23450548
BMC Health Serv Res. 2017 Dec 22;17(1):843
pubmed: 29273048
Cochrane Database Syst Rev. 2016 Nov 30;11:CD004014
pubmed: 27901278
J Midwifery Womens Health. 2012 Sep-Oct;57(5):489-94
pubmed: 22954080
Am J Obstet Gynecol. 2000 Aug;183(2):277-85
pubmed: 10942459
BJOG. 2011 Feb;118(3):338-44
pubmed: 21134102
Am J Obstet Gynecol. 2002 Jun;186(6):1160-6
pubmed: 12066091
Nurs Inq. 2003 Sep;10(3):170-6
pubmed: 12940971
Female Pelvic Med Reconstr Surg. 2014 Nov-Dec;20(6):322-7
pubmed: 25185629
Med Humanit. 2004 Jun;30(1):41-8
pubmed: 23671241
Am J Obstet Gynecol. 2013 Nov;209(5):488.e1-5
pubmed: 23770473
J Adv Nurs. 2008 Apr;62(2):228-37
pubmed: 18394035
Int Urogynecol J. 2011 Sep;22(9):1159-63
pubmed: 21604059
BMC Womens Health. 2014 Feb 03;14:20
pubmed: 24490616
BMC Womens Health. 2010 May 24;10:18
pubmed: 20497526
Lancet. 2014 Mar 1;383(9919):796-806
pubmed: 24290404
Int Urogynecol J. 2016 Feb;27(2):165-94
pubmed: 26755051
BJOG. 2009 Apr;116(5):726-30
pubmed: 19220235

Auteurs

Purva Abhyankar (P)

University of Stirling, Stirling, UK. purva.abhyankar@stir.ac.uk.

Isabelle Uny (I)

University of Stirling, Stirling, UK.

Karen Semple (K)

Nursing Midwifery and Allied Health Professions Research Unit, University of Stirling, Stirling, UK.

Sarah Wane (S)

University of Stirling, Stirling, UK.

Suzanne Hagen (S)

Nursing Midwifery and Allied Health Professions Research Unit, Glasgow Caledonian University, Glasgow, UK.

Joyce Wilkinson (J)

University of Stirling, Stirling, UK.

Karen Guerrero (K)

NHS Greater Glasgow and Clyde, Glasgow, UK.

Douglas Tincello (D)

University of Leicester, Leicester, UK.

Edward Duncan (E)

Nursing Midwifery and Allied Health Professions Research Unit, University of Stirling, Stirling, UK.

Eileen Calveley (E)

Nursing Midwifery and Allied Health Professions Research Unit, University of Stirling, Stirling, UK.

Andrew Elders (A)

Nursing Midwifery and Allied Health Professions Research Unit, Glasgow Caledonian University, Glasgow, UK.

Doreen McClurg (D)

Nursing Midwifery and Allied Health Professions Research Unit, Glasgow Caledonian University, Glasgow, UK.

Margaret Maxwell (M)

Nursing Midwifery and Allied Health Professions Research Unit, University of Stirling, Stirling, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH